Besides Wall Street's top -and-bottom-line estimates for CF (CF), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ...

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, clinical and IP package includes FDA and EMA orphan drug and ...